APA (7th ed.) Citation

Walkty, A., Adam, H., Baxter, M., Lagace-Wiens, P., Karlowsky, J., & Zhanel, G. (2019). 708. In Vitro Activity of Plazomicin vs. Clinical Isolates of Gram-Negative Bacilli, Including Aminoglycoside Nonsusceptible and Multidrug-Resistant Subsets, Recovered from Patients Across Canada as Part of the CANWARD study, 2011–2018. Open Forum Infectious Diseases, 6, S319. https://doi.org/10.1093/ofid/ofz360.776

Chicago Style (17th ed.) Citation

Walkty, Andrew, Heather Adam, Melanie Baxter, Philippe Lagace-Wiens, James Karlowsky, and George Zhanel. "708. In Vitro Activity of Plazomicin Vs. Clinical Isolates of Gram-Negative Bacilli, Including Aminoglycoside Nonsusceptible and Multidrug-Resistant Subsets, Recovered from Patients Across Canada as Part of the CANWARD Study, 2011–2018." Open Forum Infectious Diseases 6 (2019): S319. https://doi.org/10.1093/ofid/ofz360.776.

MLA (9th ed.) Citation

Walkty, Andrew, et al. "708. In Vitro Activity of Plazomicin Vs. Clinical Isolates of Gram-Negative Bacilli, Including Aminoglycoside Nonsusceptible and Multidrug-Resistant Subsets, Recovered from Patients Across Canada as Part of the CANWARD Study, 2011–2018." Open Forum Infectious Diseases, vol. 6, 2019, p. S319, https://doi.org/10.1093/ofid/ofz360.776.